Literature DB >> 22709413

Apnea testing during brain death assessment: a review of clinical practice and published literature.

J Brady Scott1, Michael A Gentile, Stacey N Bennett, MaryAnn Couture, Neil R MacIntyre.   

Abstract

The diagnosis of brain death is a complex process. Strong knowledge of neurophysiology and an understanding of brain death etiology must be used to confidently determine brain death. The key findings in brain death are unresponsiveness, and absence of brainstem reflexes in the setting of a devastating neurological injury. These findings are coupled with a series of confirmatory tests, and the diagnosis of brain death is established based on consensus recommendations. The drive to breathe in the setting of an intense ventilatory stimulus (ie, respiratory acidosis) is a critical marker of brainstem function. As a consequence, apnea testing is an important component of brain death assessment. This procedure requires close monitoring of a patient as all ventilator support is temporarily removed and Paco2 levels are allowed to rise. A "positive" test is defined by a total absence of respiratory efforts under these conditions. While apnea testing is not new, it still lacks consensus standardization regarding the actual procedure, monitored parameters, and evidence-based safety measures that may be used to prevent complications. The purpose of this report is to provide an overview of apnea testing and discuss issues related to the administration and safety of the procedure.

Entities:  

Mesh:

Year:  2013        PMID: 22709413     DOI: 10.4187/respcare.01962

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  11 in total

Review 1.  Organ donation in adults: a critical care perspective.

Authors:  Giuseppe Citerio; Marcelo Cypel; Geoff J Dobb; Beatriz Dominguez-Gil; Jennifer A Frontera; David M Greer; Alex R Manara; Sam D Shemie; Martin Smith; Franco Valenza; Eelco F M Wijdicks
Journal:  Intensive Care Med       Date:  2016-01-11       Impact factor: 17.440

2.  Variability in brain death determination in europe: looking for a solution.

Authors:  Giuseppe Citerio; Ilaria Alice Crippa; Alfio Bronco; Alessia Vargiolu; Martin Smith
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

3.  Ethical and Legal Concerns With Nevada's Brain Death Amendments.

Authors:  Greg Yanke; Mohamed Y Rady; Joseph L Verheijde
Journal:  J Bioeth Inq       Date:  2018-04-17       Impact factor: 1.352

4.  Brain death and true patient care.

Authors:  Doyen Nguyen
Journal:  Linacre Q       Date:  2016-08

5.  Apnea test during brain death assessment in mechanically ventilated and ECMO patients.

Authors:  Marco Giani; Vittorio Scaravilli; Sebastiano Maria Colombo; Andrea Confalonieri; Rosambra Leo; Elena Maggioni; Leonello Avalli; Alessia Vargiolu; Giuseppe Citerio
Journal:  Intensive Care Med       Date:  2015-11-10       Impact factor: 17.440

6.  Apnea-hypopnea index use among intensive care patients: a case series.

Authors:  Bülent Gücyetmez; Hakan Korkut Atalan
Journal:  J Med Case Rep       Date:  2014-06-06

7.  Mechanical versus humoral determinants of brain death-induced lung injury.

Authors:  Asmae Belhaj; Laurence Dewachter; Sandrine Rorive; Myriam Remmelink; Birgit Weynand; Christian Melot; Emeline Hupkens; Céline Dewachter; Jacques Creteur; Kathleen Mc Entee; Robert Naeije; Benoît Rondelet
Journal:  PLoS One       Date:  2017-07-28       Impact factor: 3.240

8.  Prolonged duration of apnea test during brain death examination in a case of intraparenchymal hemorrhage.

Authors:  Premkumar Nattanmai; Christopher R Newey; Ishpreet Singh; Keerthivaas Premkumar
Journal:  SAGE Open Med Case Rep       Date:  2017-06-22

9.  Optimal duration of the apnea test for determining brain death: Benefit of the short-term apnea test.

Authors:  Seung Min Baik; Jin Park; Tae Yoon Kim; Kyung Sook Hong
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

Review 10.  Apnea Testing for the Determination of Brain Death: A Systematic Scoping Review.

Authors:  Katharina M Busl; Ariane Lewis; Panayiotis N Varelas
Journal:  Neurocrit Care       Date:  2021-04       Impact factor: 3.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.